PTPRC and neoplasm: Analysis of tumor-infiltrating immune cells by flow cytometry (figure 1D) identified marked infiltration of CD45+ hematopoietic cells, amounting to 75.96%±15.72% of all cells in GL261 model, and 21.68%±5.33% in the CT-2A model.